(Sharecast News) - Aptamer Group said on Friday that two new pharmaceutical contracts worth £0.19m had lifted its binding 2026 order book to £1.95m, marking continued commercial momentum and strengthening validation of its Optimer synthetic-binder platform among major global drugmakers.
The AIM-traded company said the latest wins include a fourth consecutive...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE